Evidence map›Paper›PMID 35066001›Full record

ReviewRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology2022

Perspective paper about the joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[

Sofia C Vaz, Judit A Adam, Roberto C Delgado Bolton, Pierre Vera, Wouter van Elmpt, Ken Herrmann, Rodney J Hicks, Yolande Lievens, Andrea Santos, Heiko Schöder and 4 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Implications of the Harmonization of [Tomography (Ann Arbor, Mich.) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Sofia C VazNuclear Medicine-Radiopharmacology Champalimaud Foundation and Leiden University Medical Center, Lisbon, Portugal. Electronic address: sofia.vaz@fundacaochampalimaud.pt.
Judit A AdamDepartment of Radiology and Nuclear Medicine, Amsterdam University Medical Center, Amsterdam, The Netherlands. Electronic address: j.a.adam@amsterdamumc.nl.
Roberto C Delgado BoltonDepartment of Diagnostic Imaging (Radiology) and Nuclear Medicine, University Hospital San Pedro and Centre for Biomedical Research of La Rioja (CIBIR), Logroño (La Rioja), Spain.
Pierre VeraHenri Becquerel Cancer Center, QuantIF-LITIS EA 4108, Université de Rouen, Rouen, France. Electronic address: pierre.vera@chb.unicancer.fr.
Wouter van ElmptDepartment of Radiation Oncology (MAASTRO), GROW - School for Oncology, Maastricht University Medical Centre, Maastricht, The Netherlands. Electronic address: wouter.vanelmpt@maastro.nl.
Ken HerrmannDepartment of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany. Electronic address: ken.herrmann@uk-essen.de.
Rodney J HicksThe Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia. Electronic address: rod.hicks@petermac.org.
Yolande LievensRadiation Oncology Department, Ghent University Hospital and Ghent University, Ghent, Belgium. Electronic address: yolande.lievens@uzgent.be.
Andrea SantosNuclear Medicine Department, CUF Descobertas Hospital, Lisbon, Portugal.
Heiko SchöderMolecular Imaging and Therapy Service, Memorial Sloan Kettering Cancer Center, New York, USA. Electronic address: schoderh@mskcc.org.
Bernard DubrayDepartment of Radiotherapy and Medical Physics, Centre Henri Becquerel, Rouen, France; QuantIF-LITIS EA4108, University of Rouen, France. Electronic address: bernard.dubray@chb.unicancer.fr.
Dimitris VisvikisLaTIM, INSERM, UMR1101, Brest, France. Electronic address: visvikis@univ-brest.fr.
Esther G C TroostDepartment of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany; Helmholtz-Zentrum Dresden - Rossendorf, Institute of Radiooncology - OncoRay, Dresden, Germany; National Center for Tumor Diseases (NCT), Partner Site Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany, and Helmholtz Association/Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany; German Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany. Electronic address: esther.troost@uniklinikum-dresden.de.
Lioe-Fee de Geus-OeiDepartment of Radiology, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: l.f.de_geus-oei@lumc.nl.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

In "Joint EANM/SNMMI/ESTRO Practice Recommendations for the Use of 2-[18F]FDG-PET/CT External Beam Radiation Treatment Planning in Lung Cancer V1.0" clinical indications for PET-CT in (non-)small cell lung cancer are highlighted and selective nodal irradiation is discussed. Additionally, concepts about target definition, target delineation and treatment evaluation are reviewed.

Indexed as

Lung NeoplasmsPositron Emission Tomography Computed TomographyFluorodeoxyglucose F18HumansPositron-Emission TomographyRadiopharmaceuticalsFluorodeoxyglucose F18RadiopharmaceuticalsFDG-PET/CTNon-small cell lung cancerRadiation treatment planningSmall cell lung cancerTreatment response assessment

Identifiers

PMID35066001
PMCPMC9277551

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.